ES2010283A6 - Procedimiento para preparar derivados de somatostatina. - Google Patents

Procedimiento para preparar derivados de somatostatina.

Info

Publication number
ES2010283A6
ES2010283A6 ES8802038A ES8802038A ES2010283A6 ES 2010283 A6 ES2010283 A6 ES 2010283A6 ES 8802038 A ES8802038 A ES 8802038A ES 8802038 A ES8802038 A ES 8802038A ES 2010283 A6 ES2010283 A6 ES 2010283A6
Authority
ES
Spain
Prior art keywords
formula
polypeptide
protected
groups
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES8802038A
Other languages
English (en)
Spanish (es)
Inventor
Rainer Albert
Wilfried Bauer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of ES2010283A6 publication Critical patent/ES2010283A6/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Hospice & Palliative Care (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES8802038A 1987-06-29 1988-06-29 Procedimiento para preparar derivados de somatostatina. Expired ES2010283A6 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3721406 1987-06-29
DE3721407 1987-06-29

Publications (1)

Publication Number Publication Date
ES2010283A6 true ES2010283A6 (es) 1989-11-01

Family

ID=25857047

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8802038A Expired ES2010283A6 (es) 1987-06-29 1988-06-29 Procedimiento para preparar derivados de somatostatina.

Country Status (15)

Country Link
JP (1) JPS6426599A ( )
KR (1) KR890000520A ( )
AU (1) AU1840988A ( )
BE (1) BE1002663A4 ( )
CH (1) CH679045A5 ( )
DK (1) DK353788A ( )
ES (1) ES2010283A6 ( )
FR (1) FR2617171B1 ( )
GB (1) GB2206352B ( )
IL (1) IL86876A0 ( )
IT (1) IT1221065B ( )
LU (1) LU87262A1 ( )
NL (1) NL8801640A ( )
NZ (1) NZ225188A ( )
SE (1) SE8802413L ( )

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU206890B (en) * 1986-10-13 1993-01-28 Sandoz Ag Process for producing sugar-modified somatostatin peptide derivatives and pharmaceutical compositions containing them as active components
GB8826452D0 (en) * 1988-11-11 1988-12-14 Sandoz Ltd Peptide derivatives
GB8813339D0 (en) * 1988-06-06 1988-07-13 Sandoz Ltd Improvements in/relating to organic compounds
US5776894A (en) * 1988-12-05 1998-07-07 Novartis Ag Chelated somatostatin peptides and complexes thereof, pharmaceutical compositions containing them and their use in treating tumors
US5753627A (en) * 1988-12-05 1998-05-19 Novartis Ag Use of certain complexed somatostatin peptides for the invivo imaging of somatostatin receptor-positive tumors and metastasis
MY106120A (en) * 1988-12-05 1995-03-31 Novartis Ag Peptide derivatives.
US5633263A (en) * 1989-04-26 1997-05-27 The Administrators Of The Tulane Educational Fund Linear somatostatin analogs
JP2882679B2 (ja) * 1989-04-26 1999-04-12 ジ・アドミニストレーターズ・オブ・ザ・ツーレイン・エデュケイショナル・ファンド 線状ソマトスタチン類似体
GB9004017D0 (en) * 1990-02-22 1990-04-18 Krenning Eric P Improvements in or relating to organic compounds
US5632969A (en) * 1994-10-13 1997-05-27 Merck & Co., Inc. N3 S2 chelating ligands optionally radiolabelled with Tc or Re, useful for diagnostic or therapeutic applications
US5556939A (en) * 1994-10-13 1996-09-17 Merck Frosst Canada, Inc. TC or RE radionuclide labelled chelate, hexapeptide complexes useful for diagnostic or therapeutic applications
AUPN999096A0 (en) * 1996-05-22 1996-06-13 Northstar Biologicals Pty Ltd Peptides, antibodies, vaccines & uses thereof
CA2385910A1 (en) * 2000-07-31 2002-02-07 Dabur Research Foundation Somatostatin analogs for the treatment of cancer
DE60226419D1 (de) 2001-03-08 2008-06-19 Univ Tulane Somatostatin-antagonisten
MXPA03009048A (es) * 2001-04-09 2004-02-12 Univ Tulane Agonistas de la somatostatina.
KR100432178B1 (ko) * 2002-01-29 2004-05-22 홍수천 철제배관의 부식방지능을 갖는 수정화 장치
KR100462968B1 (ko) * 2002-06-10 2004-12-23 주식회사 리독스 배관내의 물의 살균, 악취제거 및 스케일 발생 방지를위한 수처리 장치

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU85269A1 (fr) * 1984-03-26 1985-10-14 Techland S A Composes nouveaux de somatostatine,procede pour leur synthese,preparation a usage veterinaire contenant lesdits composes et procede pour le traitement d'animaux
HUT42101A (en) * 1985-01-07 1987-06-29 Sandoz Ag Process for preparing stomatostatine derivatives and pharmaceutical compositions containing such compounds

Also Published As

Publication number Publication date
SE8802413L (sv) 1988-12-30
SE8802413D0 (sv) 1988-06-28
CH679045A5 ( ) 1991-12-13
DK353788D0 (da) 1988-06-27
KR890000520A (ko) 1989-03-15
BE1002663A4 (fr) 1991-04-30
NL8801640A (nl) 1989-01-16
FR2617171B1 (fr) 1994-10-14
GB2206352A (en) 1989-01-05
FR2617171A1 (fr) 1988-12-30
GB8815257D0 (en) 1988-08-03
IT8848133A0 (it) 1988-06-28
IT1221065B (it) 1990-06-21
JPS6426599A (en) 1989-01-27
AU1840988A (en) 1989-01-05
IL86876A0 (en) 1988-11-30
NZ225188A (en) 1991-04-26
GB2206352B (en) 1990-10-31
DK353788A (da) 1988-12-30
LU87262A1 (fr) 1989-03-08

Similar Documents

Publication Publication Date Title
ES2010283A6 (es) Procedimiento para preparar derivados de somatostatina.
DK0662827T3 (da) Terapeutiske og diagnostiske fremgangsmåder og sammensætninger baseret på Notch-proteiner og nucleinsyrer
FR2385688A1 (fr) Nouveaux peptides a activite biologique
DE69027989D1 (de) Il-3 MIT ZUSÄTZLICHEN CYSTEINRESTEN UND CHEMISCHE MODIFIKATIONEN DAVON
ZA953629B (en) Soluble polypeptidic fragments of lag-3 protein method of production thereof therapeutic composition anti-idiotype antibodies
GR82243B ( )
AU3133484A (en) Growth hormone releasing peptides
ES8500218A1 (es) Un procedimiento para preparar peptidos sinteticos del tipo de las calcitoninas.
PT73291B (en) Process for the preparation of novel peptides
FI953525A0 (fi) Kemiskt syntetiseringsfoerfarande foer framstaellning av ett protein eller en polypeptid
CA2020663A1 (en) Substitution analogues of magainin peptides
HUT58765A (en) Process for producing peptide compounds and pharmaceutical compositions containing them as active components
ES2009588A6 (es) Un metodo para la preparacion de un polipeptido.
CA2061167A1 (fr) Procede de purification d'une proteine fortement glycosylee
HK1013951A1 (en) Production and use of anthelmintic agents and protective immunogens
GR3004764T3 ( )
EP0730469A4 (en) MODIFIED, SHORTENED REGULATORS OF THE COMPLEMENT SYSTEM
MY106274A (en) Sdk peptides, a preparation process of the same and therapeutic compositions containing them.
ES8500217A1 (es) Un procedimiento para preparar peptidos sinteticos del tipo de las calcitoninas.
ES8204713A1 (es) Un procedimiento para aislar un polipeptido purificado
NZ209189A (en) Immunotherapeutic peptides, with amino acid sequence derived from immunoglobulin active site; pharmaceutical compositions

Legal Events

Date Code Title Description
SA6 Expiration date (snapshot 920101)

Free format text: 2008-06-29

FD1A Patent lapsed

Effective date: 20000201